Ami Organics Ltd

Acutaas Chemicals Ltd announced at its 19th Annual General Meeting held on September 24, 2026, the re-appointment of Mr. Ram Mohan Lokhande as Whole Time Director and Mrs. Anita Bandyopadhyay as Non-Executive & Independent Director. Both appointments are for a consecutive five-year term, effective from February 08, 2027, to February 07, 2032. The shareholders also approved the payment of remuneration for both directors. The filing details the qualifications and experience of both individuals, highlighting Mr. Lokhande's extensive background in API manufacturing and Mrs. Bandyopadhyay's expertise in human resources and organizational development.

Acutaas Chemicals Limited has announced the Board of Directors' approval for the acquisition of 100% equity shares of Enchem Ami Organics Private Limited (EAOPL). EAOPL, a step-down subsidiary, will become a direct wholly owned subsidiary of Acutaas Chemicals upon completion of the acquisition. The transaction involves the transfer of shares from Acutaas Chemicals Electrolytes Private Limited (ACEPL) to Acutaas Chemicals Limited at face value, amounting to Rs. 1,00,000/-. The acquisition is expected to be completed within one month and is considered an arm's length transaction. EAOPL operates in the Specialty Chemicals Industry, aligning with Acutaas Chemicals' core business.

Acutaas Chemicals Ltd has announced the closure of its trading window for designated persons and connected individuals. This closure is effective from October 1, 2026, and is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will reopen 48 hours after the declaration of the unaudited financial results for the second quarter and half year ending September 30, 2026. The date of the board meeting to approve these results will be communicated separately.

Acutaas Chemicals Limited announced that the Patent Office, Government of India, has granted a Process Patent for its invention titled "A PROCESS FOR PREPARING 2,4-DIMETHYLTHIOPHENOL". This patent is valid for 20 years from the filing date of September 21, 2017. The patented process was developed in-house at the company's R&D Centre. This marks the 11th patent granted to Acutaas Chemicals for its innovative processes and technology, strengthening its intellectual property portfolio.

Acutaas Chemicals Ltd has announced the inauguration of a new state-of-the-art Pilot Plant at its Unit-1 in Sachin, Surat. This facility is designed to support R&D for new product trials and validations. It also features a dedicated Occupational Exposure Band (OEB) 4 containment area, enabling the development and scale-up of highly potent intermediates for high potency active pharmaceutical ingredients (APIs). The company has made this intimation available on its website.

Acutaas Chemicals Ltd has announced Thursday, September 17, 2026, as the record date for determining shareholder entitlement to the final dividend for the financial year 2025-26. The proposed dividend is 50%, equivalent to ₹2.50 per equity share of ₹5 face value. This dividend, if approved by shareholders at the upcoming 19th Annual General Meeting (AGM) on September 24, 2026, will be paid within 30 days of declaration, subject to applicable tax deductions.

Acutaas Chemicals Ltd has issued a communication to its shareholders regarding the deduction of Tax Deducted at Source (TDS) on the final dividend for FY 2025-26. The Board recommended a dividend of ₹2.50 per equity share, subject to shareholder approval at the AGM on September 24, 2026. The communication details the tax implications as per the Income-tax Act, 2025, effective April 1, 2026. For resident shareholders with valid PAN, TDS is 10%; without PAN or invalid registration, it's 20%. Resident individuals receiving up to ₹10,000 dividend are exempt if Form 121 is provided. Specific documentation is required for resident non-individuals like insurance companies, mutual funds, and AIFs to claim exemptions.

Acutaas Chemicals Ltd has submitted its Annual Report for the Financial Year 2025-26, along with the Notice for its 19th Annual General Meeting (AGM). The AGM is scheduled for September 24, 2026, at 11:30 AM IST, to be held via Video Conferencing. The report details the company's performance, strategy, and financial highlights, including a significant y-o-y increase in revenue, EBITDA, and Profit After Tax. The company emphasizes its strategy of 'Focused Diversification' and 'Disciplined Growth' across pharmaceuticals, specialty chemicals, and battery chemicals. The report is available on the company's website and has been dispatched electronically to shareholders.

Acutaas Chemicals Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. The report, prepared under the BRSR Core Framework and aligned with the National Guidelines on Responsible Business Conduct (NGRBC), details the company's commitment to ethical governance, sustainable growth, inclusivity, and environmental stewardship. It covers business overview, management disclosures, and performance against Key Performance Indicators (KPIs) across nine NGRBC principles. The report is available on the company's website and has undergone reasonable assurance by TÜV SÜD South Asia Pvt. Ltd.

Acutaas Chemicals Ltd has announced its 19th Annual General Meeting (AGM) will be held on Thursday, September 24, 2026, at 11:30 AM IST. The meeting will be conducted via Video Conferencing/Other Audio Visual Means. Key agenda items include the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, and the declaration of a final dividend of 50% (₹2.50 per equity share). Additionally, the re-appointment of Mr. Chetankumar C. Vaghasia, who retires by rotation, will be considered. The cut-off date for e-voting eligibility is September 17, 2026, with the remote e-voting period from September 21 to September 23, 2026. The Annual Report for FY 2025-26 is available on the company's website.